Status:
COMPLETED
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland
Lead Sponsor:
Bayer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
In the light of ONTARGET and TRANSCEND studies results, it would be interesting to investigate the real-life telmisartan treatment tolerability. It is well known and accepted that the Real-life settin...
Eligibility Criteria
Inclusion
- hypertension
- age \> 18
- ACE-I related cough
Exclusion
- Current treatment with telmisartan
- Cholestatic disorders and severe hepatic failure
- Allergy to telmisartan
- Pregnancy and lactation period
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
2498 Patients enrolled
Trial Details
Trial ID
NCT01211171
Start Date
May 1 2009
End Date
December 1 2009
Last Update
February 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Poland